Astrana Health, Inc. (NASDAQ:ASTH) Stock Now Rated “Moderate Buy” by Wall Street Analysts

Shares of Astrana Health, Inc. (NASDAQ:ASTH) have received an average rating of “Moderate Buy” from the ten ratings firms that are covering the company, Marketbeat.com reports. Two investment analysts have rated the stock with a hold recommendation and eight have issued a buy recommendation on the company. The average 1 year target price among analysts that have updated their coverage on the stock in the last year is $49.88.

ASTH has been the subject of several research analyst reports. Wall Street Zen cut Astrana Health from a “buy” rating to a “hold” rating in a research report on Sunday, August 16th. BTIG Research boosted their price target on shares of Astrana Health from $50.00 to $65.00 and gave the stock a “buy” rating in a research note on Tuesday, July 14th. Truist Financial boosted their target price on Astrana Health from $47.00 to $55.00 and gave the stock a “buy” rating in a research report on Monday, August 10th. Oppenheimer started coverage on Astrana Health in a research note on Tuesday, September 15th. They set an “outperform” rating and a $53.00 price target for the company. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Astrana Health in a report on Thursday, August 27th.

Institutional Trading of Astrana Health

Several hedge funds have recently modified their holdings of ASTH. 325 Capital LLC lifted its position in Astrana Health by 54.0% during the fourth quarter. 325 Capital LLC now owns 1,839,076 shares of the company’s stock valued at $45,627,000 after purchasing an additional 645,123 shares during the last quarter. Dimensional Fund Advisors LP grew its stake in shares of Astrana Health by 12.5% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,368,079 shares of the company’s stock worth $33,545,000 after buying an additional 152,267 shares in the last quarter. Diamond Hill Capital Management LLC Investment Advisor bought a new stake in shares of Astrana Health in the 2nd quarter worth about $22,088,000. Bank of America Corp DE raised its position in shares of Astrana Health by 13.3% during the 1st quarter. Bank of America Corp DE now owns 574,729 shares of the company’s stock valued at $14,092,000 after buying an additional 67,628 shares in the last quarter. Finally, Bank of New York Mellon Corp purchased a new stake in shares of Astrana Health during the 2nd quarter valued at about $10,902,000. 52.77% of the stock is owned by hedge funds and other institutional investors.

Astrana Health Stock Down 0.4%

ASTH opened at $37.72 on Thursday. The company has a debt-to-equity ratio of 1.05, a quick ratio of 1.23 and a current ratio of 1.23. Astrana Health has a fifty-two week low of $18.08 and a fifty-two week high of $51.60. The firm’s fifty day moving average is $37.18 and its 200 day moving average is $37.44. The stock has a market cap of $2.10 billion, a price-to-earnings ratio of 46.00 and a beta of 1.03.

Astrana Health (NASDAQ:ASTH) last issued its earnings results on Thursday, August 6th. The company reported $0.80 earnings per share for the quarter, topping the consensus estimate of $0.34 by $0.46. Astrana Health had a net margin of 1.05% and a return on equity of 10.30%. The company had revenue of $972.52 million during the quarter, compared to the consensus estimate of $985.62 million. During the same quarter in the prior year, the firm posted $0.19 EPS. Astrana Health’s quarterly revenue was up 48.5% compared to the same quarter last year. On average, sell-side analysts forecast that Astrana Health will post 1.36 earnings per share for the current fiscal year.

Astrana Health Company Profile

Astrana Health, Inc is a healthcare enablement company that helps physicians and other healthcare providers deliver coordinated, value-based care. The company works with medical groups, independent physician associations and healthcare organizations to manage patient populations, improve clinical outcomes and coordinate services across primary, specialty and post-acute care settings.

Astrana Health provides care-management programs, population-health analytics, technology solutions and administrative support designed to help providers manage risk-based reimbursement arrangements.